Bioprogress Future2

crawford - 21 Dec'05 - 10:37 - 7980 of 8049
Inghu,
thanks for reply, we might be able to supply the film through Dexo expertise, I'm sure RT will tell us of his plans in due course.
I have to say, IMO the shares issue for Dexo will not be dilutive, it is earnings enhancing. We are paying 12.5m Euro for a company that I think should produce over £1m profit - a good purchase IMO. I am usually apprehensive on takeovers - but this one seems good value all round.
All IMO.

-I could not agree more! Dexo has e3m worth of assets, as we paid only e9m for the revenues streams and earnings potential. With profits in the order of e2m that means a total payback period of 4-1/2yrs not taking into account growth, and synergies, not to mention if they make film for us, then we do not incur the cost of settting up that plant so this is a really good deal as far as I see it. Total paback period is much less than 4-1/2yrs. Very happy!

Inghu